Treatment of premenstrual dysphoric disorder with the GABAA receptor modulating steroid antagonist Sepranolone (UC1010)—A randomized controlled trial
| Autor: | Bixo, Marie, Ekberg, Karin, Poromaa, Inger Sundström, Hirschberg, Angelica Lindén, Jonasson, Aino Fianu, Andréen, Lotta, Timby, Erika, Wulff, Marianne, Ehrenborg, Agneta, Bäckström, Torbjörn |
|---|---|
| Zdroj: | In Psychoneuroendocrinology June 2017 80:46-55 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect